HK1049795A1 - 用於治疗动脉粥样硬化的苯甲酸取代的苯并吡喃 - Google Patents

用於治疗动脉粥样硬化的苯甲酸取代的苯并吡喃 Download PDF

Info

Publication number
HK1049795A1
HK1049795A1 HK03101939.9A HK03101939A HK1049795A1 HK 1049795 A1 HK1049795 A1 HK 1049795A1 HK 03101939 A HK03101939 A HK 03101939A HK 1049795 A1 HK1049795 A1 HK 1049795A1
Authority
HK
Hong Kong
Prior art keywords
mammal
compound
benzyl
ltb
atherosclerosis
Prior art date
Application number
HK03101939.9A
Other languages
English (en)
Chinese (zh)
Inventor
罗伯特‧J‧艾洛
羅伯特‧J‧艾洛
帕特里夏-安‧布拉萨
萨拉林‧林赛
帕特里夏-安‧布拉薩
薩拉林‧林賽
Original Assignee
辉瑞产品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 辉瑞产品公司 filed Critical 辉瑞产品公司
Publication of HK1049795A1 publication Critical patent/HK1049795A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK03101939.9A 2001-06-28 2003-03-17 用於治疗动脉粥样硬化的苯甲酸取代的苯并吡喃 HK1049795A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30171201P 2001-06-28 2001-06-28
US60/301,712 2001-06-28
US32825401P 2001-10-10 2001-10-10
US60/328,254 2001-10-10

Publications (1)

Publication Number Publication Date
HK1049795A1 true HK1049795A1 (zh) 2003-05-30

Family

ID=26972559

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101939.9A HK1049795A1 (zh) 2001-06-28 2003-03-17 用於治疗动脉粥样硬化的苯甲酸取代的苯并吡喃

Country Status (12)

Country Link
EP (1) EP1270000A3 (enExample)
JP (1) JP2003034638A (enExample)
KR (1) KR20030015828A (enExample)
CN (1) CN1394602A (enExample)
AU (1) AU4239302A (enExample)
CA (1) CA2391205A1 (enExample)
CZ (1) CZ20022076A3 (enExample)
HK (1) HK1049795A1 (enExample)
HU (1) HUP0202114A3 (enExample)
IL (1) IL150340A0 (enExample)
PL (1) PL354770A1 (enExample)
SK (1) SK8682002A3 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4476934B2 (ja) * 2003-04-14 2010-06-09 明治乳業株式会社 新規ペプチドおよび免疫賦活剤、機能性食品ならびに機能性食品の製造方法
CA2574627A1 (en) * 2004-07-22 2006-02-02 Pharmacia Corporation Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist
US20090220583A1 (en) * 2005-06-09 2009-09-03 Lena Pereswetoff-Morath Method and composition for treating inflammatory disorders
US10370368B2 (en) 2015-11-30 2019-08-06 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as BLT1 antagonists
WO2017095722A1 (en) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Aryl acylsulfonamides as blt1 antagonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
MX9300312A (es) * 1992-01-23 1993-07-31 Pfizer Antagonistas benzopiranicos y relacionado de ltb.
DE4228200A1 (de) * 1992-08-25 1994-03-03 Schering Ag Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung
JP3012339B2 (ja) * 1994-10-13 2000-02-21 ファイザー・インコーポレーテッド ベンゾピランおよびベンゾ縮合化合物、それらの製造、並びにロイコトリエンｂ▲下４▼（ｌｔｂ▲下４▼）アンタゴニストとしてのそれらの用途
WO1996011920A1 (en) * 1994-10-13 1996-04-25 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4 (ltb4) antagonists
US6342510B1 (en) * 1995-06-12 2002-01-29 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
US6096906A (en) * 1996-09-16 2000-08-01 Pfizer Inc. Processes for preparing substituted chromanol derivatives
EP0963755A3 (en) * 1998-04-16 2001-03-14 Pfizer Products Inc. Use of benzopyranes for preventing allograft rejection
AU5687199A (en) * 1998-08-24 2000-03-14 Global Vascular Concepts, Inc. Use of anti-angiogenic agents for inhibiting vessel wall injury
JP2003225088A (ja) * 1999-09-10 2003-08-12 Meiji Seika Kaisha Ltd ヒト・ロイコトリエンｂ４第二受容体及びそれをコードするｄｎａ
EP1268777A2 (en) * 2000-03-17 2003-01-02 Bayer Aktiengesellschaft Regulation of human leukotriene b 4?-like g protein-coupled receptor

Also Published As

Publication number Publication date
HUP0202114A3 (en) 2004-07-28
EP1270000A3 (en) 2003-02-12
CN1394602A (zh) 2003-02-05
PL354770A1 (en) 2002-12-30
SK8682002A3 (en) 2004-08-03
HUP0202114A2 (hu) 2003-01-28
IL150340A0 (en) 2002-12-01
KR20030015828A (ko) 2003-02-25
CZ20022076A3 (cs) 2004-05-12
HU0202114D0 (enExample) 2002-09-28
AU4239302A (en) 2003-01-02
EP1270000A2 (en) 2003-01-02
JP2003034638A (ja) 2003-02-07
CA2391205A1 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
CN1304390C (zh) 新颖的γ—分泌酶抑制剂
CN1158274C (zh) 苯并吡喃类化合物及其使用方法
CN1193996C (zh) 可用作抗氧剂和5－脂氧合酶抑制剂及非甾体类抗炎药的抗炎非甾体类羧酸酯和酰胺
CN1059902C (zh) 雌激素激动剂/拮抗剂
CN1088581A (zh) 内皮素受体拮抗剂
CN1525857A (zh) 用去甲二氢愈创木酸衍生物治疗肿瘤的方法
CN1063491A (zh) 1，4-苯并硫杂吖庚因衍生物
CN1062138A (zh) Hiv反转录酶抑制剂的增效
CN1863773A (zh) 四氢吡啶衍生物
CN1777576A (zh) 用于治疗代谢紊乱的化合物
CN1278809A (zh) 取代的苯并二氢吡喃衍生物
CN1048014C (zh) 取代的吡咯类化合物及其制法、药物组合物和用途
HK1049795A1 (zh) 用於治疗动脉粥样硬化的苯甲酸取代的苯并吡喃
CN1113386A (zh) 取代的犬尿氨酸、其制备方法及其作为药物的用途
CN1100301A (zh) 用于神经保护的药物
JPH10503779A (ja) フェノキシフェニル酢酸誘導体
CN1042354A (zh) (RS)-2-(2，3-二氢-5-羟基-4，6，7-三甲苯氧茚基)乙酸和2-2，3-二氢-5-乙酰氧基-4，6，7-三甲基氧茚基)乙酸及其酯，用作粘液调节剂和抗hyschaemic药物及其制备方法
CN1254243C (zh) 包含白屈菜碱或其衍生物的药物组合物
CN1666982A (zh) 来自牛樟芝菌丝体的新混合物和化合物及其用途
CN1396906A (zh) 钙受体拮抗剂化合物
CN1058016A (zh) 用于治疗与白三烯有关疾病的苯甲酸衍生物
CN1055472C (zh) 噁唑并喹啉酮衍生物,它们的制备及其在治疗上的应用
CN1914151A (zh) 作为环氧合酶－2抑制剂的二芳基－2(5h)－呋喃酮类的释放一氧化氮的前药
CN1528745A (zh) 吡咯烷类基质金属蛋白酶抑制剂及其制备方法
CN1138852A (zh) 哒嗪酮衍生物